Yahoo
KSE - Delayed Quote KRW

GC Biopharma Corp. (006280.KS)

133,900.00 +3,700.00 (+2.84%)
As of 11:53:01 AM GMT+9. Market Open.
View in AlphaSpace Currency in KRW All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
184,284,176.52
99,462,778.24
-53,460,079.25
-5,472,809.76
119,154,310.88
Investing Cash Flow
-98,305,054.85
-186,790,057.52
-67,894,169.56
-150,243,304.36
-205,259,306.66
Financing Cash Flow
-136,736,293.04
111,580,177.85
93,845,334.70
100,511,823.14
-2,480,542.68
End Cash Position
33,426,003.89
49,372,311.05
22,563,430.29
49,706,128.32
105,365,807.60
Capital Expenditure
-128,000,289.51
-105,278,481.93
-42,391,239.19
-125,991,501.23
-94,690,240.05
Issuance of Debt
1,680,011,102.59
1,219,918,115.79
1,500,526,868.40
1,193,247,000
836,759,000
Repayment of Debt
-1,790,157,195.79
-1,080,474,295.79
-1,378,846,000
-1,060,216,000
-848,712,643.12
Free Cash Flow
56,283,887.01
-5,815,703.69
-95,851,318.44
-131,464,310.99
24,464,070.83
12/31/2022 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: